| Dr Amanda W Speicher, MD | |
|
165 State St, Suite 200, New London, CT 06320-6397 | |
| (860) 443-0036 | |
| (860) 443-4284 |
| Full Name | Dr Amanda W Speicher |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 27 Years |
| Location | 165 State St, New London, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376843011 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 39821 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Westerly Hospital | Westerly, RI | Hospital |
| Lawrence & Memorial Hospital | New london, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Connecticut Behavioral Health Assoc, P.c. | 4385532373 | 35 |
News Archive
An investigational combination of drugs already approved to treat obesity, migraine and epilepsy produced up to a 10 percent weight loss in obese individuals participating in a one-year clinical trial, according to researchers at Duke University Medical Center.
The defense department announced Sunday that it would create a team to assist U.S. doctors responding to new Ebola cases, while the government issued more stringent guidelines for protective garb for health care workers treating Ebola patients. In addition, The Wall Street Journal profiles a biologist who has been working since 1997 on an Ebola vaccine which has been proven to block the disease in monkeys.
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver cancer to develop from liver cells.
› Verified 1 days ago
| Entity Name | Connecticut Behavioral Health Assoc, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629158126 PECOS PAC ID: 4385532373 Enrollment ID: O20040310000567 |
News Archive
An investigational combination of drugs already approved to treat obesity, migraine and epilepsy produced up to a 10 percent weight loss in obese individuals participating in a one-year clinical trial, according to researchers at Duke University Medical Center.
The defense department announced Sunday that it would create a team to assist U.S. doctors responding to new Ebola cases, while the government issued more stringent guidelines for protective garb for health care workers treating Ebola patients. In addition, The Wall Street Journal profiles a biologist who has been working since 1997 on an Ebola vaccine which has been proven to block the disease in monkeys.
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver cancer to develop from liver cells.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amanda W Speicher, MD Po Box 2170, New London, CT 06320-2170 Ph: (860) 443-0036 | Dr Amanda W Speicher, MD 165 State St, Suite 200, New London, CT 06320-6397 Ph: (860) 443-0036 |
News Archive
An investigational combination of drugs already approved to treat obesity, migraine and epilepsy produced up to a 10 percent weight loss in obese individuals participating in a one-year clinical trial, according to researchers at Duke University Medical Center.
The defense department announced Sunday that it would create a team to assist U.S. doctors responding to new Ebola cases, while the government issued more stringent guidelines for protective garb for health care workers treating Ebola patients. In addition, The Wall Street Journal profiles a biologist who has been working since 1997 on an Ebola vaccine which has been proven to block the disease in monkeys.
Even though young patients with metastatic colorectal cancer tend to be more fit and receive more intensive treatment than older patients, both groups survive for roughly the same amount of time, according to a new study by Dana-Farber Cancer Institute investigators.
Patients with advanced hepatocellular (or liver) cancer have high mortality rates, with existing drugs demonstrating only a small, but significant survival advantage. By combining a zebrafish model of liver cancer with data from human tumors, researchers from the Icahn School of Medicine at Mount Sinai hope to identify potential genes of interest that can be targeted for new treatments for hepatocellular carcinoma, the most common form of liver cancer to develop from liver cells.
› Verified 1 days ago
Bilal Hameed, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 194 Howard St Ste 1, New London, CT 06320 Phone: 860-440-0640 Fax: 860-865-2397 | |
Dr. Sherrie Sharp, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 255 Hempstead St, New London, CT 06320 Phone: 860-443-2896 | |
Dr. Henry F Crabbe, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5 Shaws Cv Ste 207, New London, CT 06320 Phone: 860-444-8877 Fax: 860-444-9660 | |
Dr. Louis Henry Reich, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 292 Montauk Avenue, New London, CT 06320 Phone: 860-443-1200 Fax: 860-442-4488 | |
Dr. Stephen Glenn Vance, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 21 Montauk Ave, New London, CT 06320 Phone: 860-439-6400 Fax: 860-271-4797 | |
Dr. Ammar S Traboulsi, MD Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 41 Fair Harbour Pl, New London, CT 06320 Phone: 860-437-6914 | |
Amy Stevens, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-271-4655 |